| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $446K | -96.2% |
| SG&A Expense | $3.3M | -55.8% |
| Operating Income | -$4.2M | +78.5% |
| Pre-tax Income | -$8.3M | +48.8% |
| Income Tax | -$3.0M | +0.0% |
| Net Income | -$8.3M | +37.3% |
| EPS (Basic) | -$0.88 | +99.2% |
| EPS (Diluted) | -$0.88 | +99.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Current Assets | $3.1M | +90.2% |
| Total Assets | $3.1M | +90.2% |
| Current Liabilities | $299K | -90.5% |
| Total Liabilities | $402K | -88.4% |
| Stockholders' Equity | $2.7M | +243.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.3M | +82.0% |
| Investing Cash Flow | -$132K | +78.0% |
| Financing Cash Flow | $4.8M | +10.9% |